FDA
approval
· 2012-12-20
FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Fresenius Kabi USA, LLC)
Summary
FDA approved a supplemental application for Levothyroxine Sodium (Levothyroxine Sodium Anhydrous) by Fresenius Kabi USA, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM ANHYDROUS)